Siegfried Holding Ltd

SFZN

Equity

ISIN CH0014284498 / Valor 1428449

SIX Swiss Exchange (2024-09-18)

CHF 1,160.00-0.17%

Siegfried Holding Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Siegfried Holding Ltd is a globally leading outsourcing partner that specializes in contract development and manufacturing of active pharmaceutical ingredients, intermediates, and finished dosage forms. With a commitment to reducing their carbon footprint, Siegfried offers a comprehensive range of services from process development and optimization to registration, production, packaging, and logistics. Founded in 1873 in Zofingen, Switzerland, Siegfried has evolved into a global player with state-of-the-art facilities and cutting-edge technologies, serving over 500 customers globally and producing approximately 200 out of 1500 APIs approved by the FDA. With a global network of 12 facilities in seven countries on three continents, Siegfried is a key player in the pharmaceutical industry, producing over 100 million doses of Covid-19 vaccines and reaching up to one billion people with their products annually.

Summarized from source with an LLMView SourceSector: Healthcare

Record Sales Growth

Siegfried Holding Ltd reported record sales for the full year of 2022, reaching an all-time high of 1.229 billion Swiss francs (CHF). This represents a 15.6 percent increase in local currencies compared to the previous year, driven by strong performance in both Drug Substances and Drug Products.

Core EBITDA Increase

For the full year of 2022, Siegfried Holding Ltd achieved a core EBITDA of CHF 272.5 million, marking a 31.5 percent increase from CHF 207.2 million in 2021. This resulted in a core EBITDA margin of 22.2 percent, surpassing the 20 percent mark for the first time on a full-year basis.

Net Profit Growth

Siegfried Holding Ltd's core net profit for 2022 grew by 34.1 percent to CHF 127.8 million, up from CHF 95.3 million in 2021. The net profit according to Swiss GAAP FER was even higher, amounting to CHF 156.5 million.

Dividend Increase

The Board of Directors of Siegfried Holding Ltd will propose an increase in the payout to shareholders to 3.40 Swiss francs per share at the Annual General Meeting. This is up from CHF 3.20 per share in the previous year, and the payout will be made by reducing the nominal value of the shares through a capital reduction.

Cash Flow and Debt Position

Siegfried Holding Ltd reported a strong cash flow from operating activities of CHF 142.3 million for 2022, compared to CHF 119.7 million in 2021. Free cash flow amounted to CHF 27.2 million, and the company ended the year with cash and cash equivalents of CHF 91.5 million. Net debt stood at CHF 418.5 million, with a ratio of 1.54 to core EBITDA, and an equity ratio of 44.1 percent.

Summarized from source with an LLMView Source

Key figures

49.7%1Y

39.6%3Y

189%5Y

Performance

22.2%1Y

30.5%3Y

30.2%5Y

Volatility